2010 Annual Saturday

20 / 54

Chicago, IL - 2010 ASCO Annual Meeting: Hagop Kantarjian, MD, addresses the Novel Therapies Press Conference about Abstract "Dasatinib compared to imatinib in patients with newly diagnosed chronic-phase chronic myelogenous leukemia in chronic phase (CML-CP): 12-month efficacy and safety from the phase 3 DASISION study" at the American Society of Clinical Oncology Annual Meeting on Saturday, June 5, 2010. Over 32,000 physicians, researchers and healthcare professionals from over 100 countries attended the meeting, which was held at McCormick Place and featured the latest innovations in cancer research, quality, practice and technology. Date: Saturday June 5, 2010 Photo by © ASCO/Scott Morgan 2010 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org

$Chicago, IL - 2010 ASCO Annual Meeting: Amar J. Gajjar, MD, addresses the Novel Therapies Press Conference about Abstract “A phase I pharmacokinetic trial of sonic hedgehog (SHH) antagonist GDC-0449 in pediatric patients with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study (PBTC 25)” at the American Society of Clinical Oncology Annual Meeting on Saturday, June 5, 2010. Over 32,000 physicians, researchers and healthcare professionals from over 100 countries attended the meeting, which was held at McCormick Place and featured the latest innovations in cancer research, quality, practice and technology. Date: Saturday June 5, 2010 Photo by © ASCO/Scott Morgan 2010 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org$